Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for September 24th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 24th:

RH (RH - Free Report) : This retailer of home furnishings has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.4% over the last 60 days.

RH Price and Consensus

RH Price and Consensus

RH price-consensus-chart | RH Quote

 

RH’s shares gained 9.8% over the last one month compared with the S&P 500’s decline of 4.7%. The company possesses a Momentum Score of A.

RH Price

RH Price

RH price | RH Quote

 

Ready Capital Corporation (RC - Free Report) : This real estate finance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.

Ready Capital’s shares gained 16.3% over the last one month. The company possesses a Momentum Score of A.

Salesforce.com, inc. (CRM - Free Report) : This enterprise cloud computing solutions developer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.9% over the last 60 days.

Salesforce’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.

PennyMac Financial Services, Inc. (PFSI - Free Report) : This mortgage banking and investment management company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 48% over the last 60 days.

PennyMac Financial Services’ shares gained 15.3% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here.

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>